We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $52.62 which represents a slight increase of $0.66 or 1.27% from the prior close of $51.96. The stock opened at $52.23 and touched a ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...